Tom Gayner acquired 2.15 Million Novo Nordisk shares worth $277 Million. That's 2.76% of their equity portfolio (9th largest holding). The first Novo Nordisk trade was made in Q4 2009. Since then Tom Gayner bought shares four more times and sold shares on twelve occasions. The stake costed the investor $99 Million, netting the investor a gain of 179% so far.